Nedocromil
Jump to navigation
Jump to search
Names | |
---|---|
Trade names | Alocril, Tilade, Rapitil, others |
| |
Clinical data | |
Drug class | Mast cell stabilizer[1] |
Main uses | Allergic conjunctivitis[1] |
Side effects | Headache, irritated eyes, stuffy nose[1] |
Routes of use | Inhalation, eye drops |
External links | |
AHFS/Drugs.com | Monograph |
MedlinePlus | a601243 |
Legal | |
Legal status | |
Pharmacokinetics | |
Protein binding | 89% |
Metabolism | Not metabolized |
Elimination half-life | ~3.3 hours |
Excretion | Excreted unchanged |
Chemical and physical data | |
Formula | C19H17NO7 |
Molar mass | 371.345 g·mol−1 |
3D model (JSmol) | |
| |
|
Nedocromil, sold under the brand name Alocil among others, is a medication used to treat allergic conjunctivitis.[1] It is used as an eye drop.[2]
Common side effects include headache, irritated eyes, and stuffy nose.[1] There is no evidence of harm with use in pregnancy.[3] It is a mast cell stabilizer, which decreases the release of histamine.[2]
Nedocromil was approved for medical use in the United States in 1999.[1] In the United States it costs about 230 USD for a 5 ml bottle.[4]
Medical use
It is used to treat allergic conjunctivitis.[5]
It was previously used for asthma.[6]
Society and culture
US Production of inhaled nedocromil stopped in 2008.[7]
References
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 "Nedocromil (EENT) Monograph for Professionals". Drugs.com. Archived from the original on 4 March 2021. Retrieved 12 November 2021.
- ↑ 2.0 2.1 Allen H. Dajani S (ed.). "ALOCRIL (nedocromil sodium) solution/ drops". DailyMed. U.S. National Institutes of Health. Archived from the original on 20 May 2014. Retrieved 17 May 2013.
- ↑ "Nedocromil ophthalmic (Alocril) Use During Pregnancy". Drugs.com. Archived from the original on 28 November 2020. Retrieved 12 November 2021.
- ↑ "Nedocromil Prices, Coupons & Savings Tips - GoodRx". GoodRx. Retrieved 12 November 2021.
- ↑ Castillo M, Scott NW, Mustafa MZ, Mustafa MS, Azuara-Blanco A (June 2015). "Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis" (PDF). The Cochrane Database of Systematic Reviews. 6 (6): CD009566. doi:10.1002/14651858.CD009566.pub2. hdl:2164/6048. PMID 26028608. Archived from the original on 2021-08-28. Retrieved 2021-07-16.
- ↑ BNF 81: March-September 2021. BMJ Group and the Pharmaceutical Press. 2021. p. 255. ISBN 978-0857114105.
- ↑ "Questions and Answers:Phase-Out of CFC Metered-Dose Inhalers Containing flunisolide, triamcinolone, metaproterenol, pirbuterol, albuterol and ipratropium in combination, cromolyn, and nedocromil". U.S. Food and Drug Administration. 13 April 2010. Archived from the original on 2 February 2012.
External links
Identifiers: |
|
---|
Categories:
- Pages using duplicate arguments in template calls
- Chemical articles with unknown parameter in Infobox drug
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugs missing an ATC code
- Mast cell stabilizers
- Ophthalmology drugs
- Dicarboxylic acids
- Nitrogen heterocycles
- Oxygen heterocycles
- Heterocyclic compounds with 3 rings
- Diketones
- RTT
- All stub articles
- Respiratory system drug stubs